Special Population Considerations Elderly patients may benefit from tirzepatides robust efficacy while requiring careful attention to gastrointestinal tolerability and potential drug interactions
To determine the C rating of a battery in your solar system when it is not specified on the spec sheet, you may need to gather some additional information and perform calculations
A 2025 Endocrine Society presentation put the figure near 40 percent for semaglutide, and a 2024 Circulation clinical primer reported a similar range across the drug class
The active ingredient is semaglutide, and it is approved by the FDA for use in adults and children over 12 who have obesity or are overweight with other health risks
N Engl J Med 375(4): 311-322
Satapathy, S., Bandyopadhyay, D., Patro, B